Brian Grow insider trades

Open-market stock purchases and sales by Brian Grow, Chief Commercial Officer at Organogenesis Holdings Inc, from SEC Form 4 filings since Dec 10, 2018.

Recent trades

DateStockTradeValue
Feb 18, 2026ORGO Organogenesis Holdings IncSold (not open market)$45.2K
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 18, 2026ORGO Organogenesis Holdings IncSold (not open market)$45.6K
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 18, 2026ORGO Organogenesis Holdings IncBought (not open market)—
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$12.5K
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$70.5K
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$39.4K
Feb 15, 2026ORGO Organogenesis Holdings IncSold (not open market)$41.6K

Companies traded

  • ORGO Organogenesis Holdings Inc: other filings, last Feb 18, 2026

Get free alerts when Brian Grow files a new trade →